The average one-year price target for Century Therapeutics (NasdaqCM:IPSC) has been revised to $4.20 / share. This is an increase of 10.75% from the prior estimate of $3.79 dated January 11, 2026. The ...
Century Therapeutics Inc. (NASDAQ:IPSC) is one of the best fast growing penny stocks to buy according to analysts. On January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results